BRAINSWAY LTD-ADR (BWAY) Fundamental Analysis & Valuation
NASDAQ:BWAY • US10501L1061
Current stock price
15.81 USD
+0.48 (+3.13%)
At close:
15.81 USD
0 (0%)
After Hours:
This BWAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. BWAY Profitability Analysis
1.1 Basic Checks
- BWAY had positive earnings in the past year.
- In the past year BWAY had a positive cash flow from operations.
- In the past 5 years BWAY reported 4 times negative net income.
- In multiple years BWAY reported negative operating cash flow during the last 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 5.53%, BWAY belongs to the best of the industry, outperforming 80.85% of the companies in the same industry.
- BWAY has a better Return On Equity (8.92%) than 80.32% of its industry peers.
- BWAY has a Return On Invested Capital of 2.75%. This is in the better half of the industry: BWAY outperforms 70.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.53% | ||
| ROE | 8.92% | ||
| ROIC | 2.75% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- BWAY's Profit Margin of 12.73% is amongst the best of the industry. BWAY outperforms 86.17% of its industry peers.
- With a decent Operating Margin value of 5.78%, BWAY is doing good in the industry, outperforming 71.81% of the companies in the same industry.
- BWAY has a better Gross Margin (74.92%) than 84.57% of its industry peers.
- BWAY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.78% | ||
| PM (TTM) | 12.73% | ||
| GM | 74.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
2. BWAY Health Analysis
2.1 Basic Checks
- BWAY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- There is no outstanding debt for BWAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 8.60 indicates that BWAY is not in any danger for bankruptcy at the moment.
- BWAY has a better Altman-Z score (8.60) than 84.57% of its industry peers.
- BWAY has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
- BWAY has a Debt to FCF ratio of 0.37. This is amongst the best in the industry. BWAY outperforms 92.02% of its industry peers.
- A Debt/Equity ratio of 0.08 indicates that BWAY is not too dependend on debt financing.
- With a decent Debt to Equity ratio value of 0.08, BWAY is doing good in the industry, outperforming 67.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.37 | ||
| Altman-Z | 8.6 |
ROIC/WACC0.32
WACC8.51%
2.3 Liquidity
- BWAY has a Current Ratio of 3.19. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 3.19, BWAY is in line with its industry, outperforming 55.85% of the companies in the same industry.
- A Quick Ratio of 3.02 indicates that BWAY has no problem at all paying its short term obligations.
- BWAY's Quick ratio of 3.02 is fine compared to the rest of the industry. BWAY outperforms 63.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.19 | ||
| Quick Ratio | 3.02 |
3. BWAY Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 117.91% over the past year.
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%
3.2 Future
- BWAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.62% yearly.
- The Revenue is expected to grow by 23.69% on average over the next years. This is a very strong growth
EPS Next Y25.19%
EPS Next 2Y39.53%
EPS Next 3Y35.62%
EPS Next 5YN/A
Revenue Next Year25.98%
Revenue Next 2Y26.09%
Revenue Next 3Y23.69%
Revenue Next 5YN/A
3.3 Evolution
4. BWAY Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 25.10, the valuation of BWAY can be described as expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of BWAY indicates a somewhat cheap valuation: BWAY is cheaper than 75.00% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of BWAY to the average of the S&P500 Index (27.87), we can say BWAY is valued inline with the index average.
- With a Price/Forward Earnings ratio of 20.02, BWAY is valued on the expensive side.
- Based on the Price/Forward Earnings ratio, BWAY is valued cheaper than 80.85% of the companies in the same industry.
- BWAY's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 38.51.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.1 | ||
| Fwd PE | 20.02 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BWAY indicates a somewhat cheap valuation: BWAY is cheaper than 64.89% of the companies listed in the same industry.
- 76.60% of the companies in the same industry are more expensive than BWAY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.51 | ||
| EV/EBITDA | 115.77 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as BWAY's earnings are expected to grow with 35.62% in the coming years.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y39.53%
EPS Next 3Y35.62%
5. BWAY Dividend Analysis
5.1 Amount
- BWAY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BWAY Fundamentals: All Metrics, Ratios and Statistics
15.81
+0.48 (+3.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11 2026-03-11/dmh
Earnings (Next)05-11 2026-05-11
Inst Owners5.26%
Inst Owner Change0.04%
Ins Owners15.17%
Ins Owner Change0%
Market Cap632.92M
Revenue(TTM)N/A
Net Income(TTM)6.25M
Analysts85.71
Price Target0.05 (-99.68%)
Short Float %N/A
Short Ratio0.68
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.34%
Min EPS beat(2)35.56%
Max EPS beat(2)95.12%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-22.64%
Max EPS beat(4)95.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-11.32%
Revenue beat(16)6
Avg Revenue beat(16)-26.49%
PT rev (1m)-59.44%
PT rev (3m)-59.64%
EPS NQ rev (1m)-51.02%
EPS NQ rev (3m)-51.14%
EPS NY rev (1m)-51.02%
EPS NY rev (3m)-48.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.1 | ||
| Fwd PE | 20.02 | ||
| P/S | 12.89 | ||
| P/FCF | 34.51 | ||
| P/OCF | 28.42 | ||
| P/B | 9.03 | ||
| P/tB | 9.03 | ||
| EV/EBITDA | 115.77 |
EPS(TTM)0.63
EY3.98%
EPS(NY)0.79
Fwd EY4.99%
FCF(TTM)0.46
FCFY2.9%
OCF(TTM)0.56
OCFY3.52%
SpS1.23
BVpS1.75
TBVpS1.75
PEG (NY)1
PEG (5Y)N/A
Graham Number4.98084 (-68.5%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.53% | ||
| ROE | 8.92% | ||
| ROCE | 3.26% | ||
| ROIC | 2.75% | ||
| ROICexc | 15.43% | ||
| ROICexgc | 15.43% | ||
| OM | 5.78% | ||
| PM (TTM) | 12.73% | ||
| GM | 74.92% | ||
| FCFM | 37.36% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score5
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.37 | ||
| Debt/EBITDA | 1.21 | ||
| Cap/Depr | 207.6% | ||
| Cap/Sales | 8.01% | ||
| Interest Coverage | 26.28 | ||
| Cash Conversion | 470.69% | ||
| Profit Quality | 293.55% | ||
| Current Ratio | 3.19 | ||
| Quick Ratio | 3.02 | ||
| Altman-Z | 8.6 |
F-Score5
WACC8.51%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
EPS Next Y25.19%
EPS Next 2Y39.53%
EPS Next 3Y35.62%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%
Revenue Next Year25.98%
Revenue Next 2Y26.09%
Revenue Next 3Y23.69%
Revenue Next 5YN/A
EBIT growth 1Y147.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.54%
EBIT Next 3Y43.13%
EBIT Next 5Y44.57%
FCF growth 1Y441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y749.36%
OCF growth 3Y127.03%
OCF growth 5YN/A
BRAINSWAY LTD-ADR / BWAY Fundamental Analysis FAQ
What is the fundamental rating for BWAY stock?
ChartMill assigns a fundamental rating of 5 / 10 to BWAY.
Can you provide the valuation status for BRAINSWAY LTD-ADR?
ChartMill assigns a valuation rating of 5 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Fairly Valued.
Can you provide the profitability details for BRAINSWAY LTD-ADR?
BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.
How financially healthy is BRAINSWAY LTD-ADR?
The financial health rating of BRAINSWAY LTD-ADR (BWAY) is 7 / 10.